Sangamo Therapeutics Inc (SGMO) — Cash Flow Quality Index

Latest as of September 2024: 1.10x

Sangamo Therapeutics Inc (SGMO) has a Cash Flow Quality Index of 1.10x as of September 2024. Operating cash flow of $11.76 Million exceeds net income of $10.67 Million, indicating high earnings quality where cash backs reported profits. Explore how much of Sangamo Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.10x

Operating CF / Net Income

Operating Cash Flow

$11.76 Million

USD

Net Income

$10.67 Million

USD

Data as of

Sep 2024

Most recent filing

Annual Cash Flow Quality Index for Sangamo Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Sangamo Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Sangamo Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.